{
  "DOI": "10.1007/s10689-017-0066-y",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-017-0066-y",
  "alternative-id": [
    "66"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Vasen",
      "given": "Hans F. A.",
      "sequence": "first"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        12,
        4
      ]
    ],
    "date-time": "2017-12-04T09:38:21Z",
    "timestamp": 1512380301000
  },
  "deposited": {
    "date-parts": [
      [
        2018,
        1,
        16
      ]
    ],
    "date-time": "2018-01-16T10:10:12Z",
    "timestamp": 1516097412000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        7,
        22
      ]
    ],
    "date-time": "2022-07-22T11:28:47Z",
    "timestamp": 1658489327822
  },
  "is-referenced-by-count": 7,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2017,
        12,
        4
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2018,
          1
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2017,
            12,
            4
          ]
        ],
        "date-time": "2017-12-04T00:00:00Z",
        "timestamp": 1512345600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-017-0066-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0066-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-017-0066-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1-3",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2017,
        12,
        4
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        12,
        4
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2018,
        1
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s10689-017-0057-z",
      "author": "CA Barnes",
      "doi-asserted-by": "publisher",
      "journal-title": "Fam Cancer",
      "key": "66_CR1",
      "unstructured": "Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P et al (2017) Development of a high risk pancreatic screening clinic using 3.0 T MRI. Fam Cancer. \n                        https://doi.org/10.1007/s10689-017-0057-z\n                        \n                    .",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nrgastro.2012.111",
      "author": "DK Bartsch",
      "doi-asserted-by": "crossref",
      "first-page": "445",
      "issue": "8",
      "journal-title": "Nat Rev Gastroenterol Hepatol",
      "key": "66_CR2",
      "unstructured": "Bartsch DK, Gress TM, Langer P (2012) Familial pancreatic cancer—current knowledge. Nat Rev Gastroenterol Hepatol 9(8):445–453",
      "volume": "9",
      "year": "2012"
    },
    {
      "DOI": "10.1200/JCO.2017.72.3502",
      "author": "K Shindo",
      "doi-asserted-by": "crossref",
      "first-page": "3382",
      "issue": "30",
      "journal-title": "J Clin Oncol",
      "key": "66_CR3",
      "unstructured": "Shindo K, Yu J, Suenaga M, Fesharakizadeh S, Cho C, Macgregor-Das A et al (2017) Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma. J Clin Oncol 35(30):3382–3390",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2014.153",
      "author": "DB Zhen",
      "doi-asserted-by": "crossref",
      "first-page": "569",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "66_CR4",
      "unstructured": "Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG et al (2015) BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med 17(7):569–577",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1158/2159-8290.CD-15-0402",
      "author": "NJ Roberts",
      "doi-asserted-by": "crossref",
      "first-page": "166",
      "issue": "2",
      "journal-title": "Cancer Discov",
      "key": "66_CR5",
      "unstructured": "Roberts NJ, Norris AL, Petersen GM, Bondy ML, Brand R, Gallinger S et al (2016) Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discov 6(2):166–175",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2017.85",
      "author": "KG Chaffee",
      "doi-asserted-by": "publisher",
      "journal-title": "Genet Med",
      "key": "66_CR6",
      "unstructured": "Chaffee KG, Oberg AL, McWilliams RR, Majithia N, Allen BA, Kidd J et al (2017) Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genet Med. \n                        https://doi.org/10.1038/gim.2017.85",
      "year": "2017"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-0403",
      "author": "FA Snoo de",
      "doi-asserted-by": "crossref",
      "first-page": "7151",
      "issue": "21",
      "journal-title": "Clin Cancer Res",
      "key": "66_CR7",
      "unstructured": "de Snoo FA, Bishop DT, Bergman W, van Leeuwen I, van der Drift C, van Nieuwpoort FA et al (2008) Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res 14(21):7151–7157",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1093/jnci/94.18.1358",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "1358",
      "issue": "18",
      "journal-title": "J Natl Cancer Inst",
      "key": "66_CR8",
      "unstructured": "Thompson D, Easton DF, Breast Cancer Linkage C (2002) Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94(18):1358–1365",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jmg.2004.028829",
      "author": "CJ Asperen van",
      "doi-asserted-by": "crossref",
      "first-page": "711",
      "issue": "9",
      "journal-title": "J Med Genet",
      "key": "66_CR9",
      "unstructured": "van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF et al (2005) Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 42(9):711–719",
      "volume": "42",
      "year": "2005"
    },
    {
      "DOI": "10.1136/gutjnl-2017-314057",
      "author": "P Moller",
      "doi-asserted-by": "publisher",
      "journal-title": "Gut",
      "key": "66_CR10",
      "unstructured": "Moller P, Seppala TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D et al (2017) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut. \n                        https://doi.org/10.1136/gutjnl-2017-314057",
      "year": "2017"
    },
    {
      "DOI": "10.1093/jnci/91.15.1310",
      "author": "C Breast Cancer Linkage",
      "doi-asserted-by": "crossref",
      "first-page": "1310",
      "issue": "15",
      "journal-title": "J Natl Cancer Inst",
      "key": "66_CR11",
      "unstructured": "Breast Cancer Linkage C (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310–1316",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1200/JCO.2015.64.0730",
      "author": "H Vasen",
      "doi-asserted-by": "crossref",
      "first-page": "2010",
      "issue": "17",
      "journal-title": "J Clin Oncol",
      "key": "66_CR12",
      "unstructured": "Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthai E, Carrato A et al (2016) Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three european expert centers. J Clin Oncol 34(17):2010–2019",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.7326/0003-4819-131-4-199908170-00003",
      "author": "TA Brentnall",
      "doi-asserted-by": "crossref",
      "first-page": "247",
      "issue": "4",
      "journal-title": "Ann Intern Med",
      "key": "66_CR13",
      "unstructured": "Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131(4):247–255",
      "volume": "131",
      "year": "1999"
    },
    {
      "DOI": "10.1053/j.gastro.2012.01.005",
      "author": "MI Canto",
      "doi-asserted-by": "crossref",
      "first-page": "796",
      "issue": "4",
      "journal-title": "Gastroenterology",
      "key": "66_CR14",
      "unstructured": "Canto MI, Hruban RH, Fishman EK, Kamel IR, Schulick R, Zhang Z et al (2012) Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 142(4):796–804 (quiz e14-5)",
      "volume": "142",
      "year": "2012"
    },
    {
      "DOI": "10.1136/gut.2008.171611",
      "author": "P Langer",
      "doi-asserted-by": "crossref",
      "first-page": "1410",
      "issue": "10",
      "journal-title": "Gut",
      "key": "66_CR15",
      "unstructured": "Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M et al (2009) Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 58(10):1410–1418",
      "volume": "58",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s11605-011-1781-6",
      "author": "W Al-Sukhni",
      "doi-asserted-by": "crossref",
      "first-page": "771",
      "issue": "4",
      "journal-title": "J Gastrointest Surg",
      "key": "66_CR16",
      "unstructured": "Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R et al (2012) Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. J Gastrointest Surg 16(4):771–783",
      "volume": "16",
      "year": "2012"
    },
    {
      "DOI": "10.1136/gutjnl-2012-303108",
      "author": "MI Canto",
      "doi-asserted-by": "crossref",
      "first-page": "339",
      "issue": "3",
      "journal-title": "Gut",
      "key": "66_CR17",
      "unstructured": "Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I et al (2013) International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62(3):339–347",
      "volume": "62",
      "year": "2013"
    },
    {
      "DOI": "10.1136/gutjnl-2014-308008",
      "author": "F Harinck",
      "doi-asserted-by": "crossref",
      "first-page": "1505",
      "issue": "9",
      "journal-title": "Gut",
      "key": "66_CR18",
      "unstructured": "Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM et al (2016) A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals. Gut 65(9):1505–1513",
      "volume": "65",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ebiom.2015.11.005",
      "author": "PV Pandharipande",
      "doi-asserted-by": "crossref",
      "first-page": "1980",
      "issue": "12",
      "journal-title": "EBioMedicine",
      "key": "66_CR19",
      "unstructured": "Pandharipande PV, Jeon A, Heberle CR, Dowling EC, Kong CY, Chung DC et al (2015) Screening for pancreatic adenocarcinoma in BRCA2 mutation carriers: results of a disease simulation model. EBioMedicine 2(12):1980–1986",
      "volume": "2",
      "year": "2015"
    }
  ],
  "reference-count": 19,
  "references-count": 19,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-017-0066-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "17"
}